click below
click below
Normal Size Small Size show me how
Pharm- Arrythmias
Pharmacology 9/17/08
| Question | Answer |
|---|---|
| Cardiac Action Potential Phase 4 | Diastole Cells are polarized and resting |
| Cardiac Action Potential Phase 0 | Depolarization Rapid influx of Na and then slow influx of calcium causes the cell to depolarize. Alteration of the sodim and calcium channels effect the rate of impulse propagation through the heart. |
| Cardiac Action Potential Phase 1 | Na channels close leading to rapid depolarization |
| Cardiac Action Potential Phase 2 | Refractory Period Little Activity |
| Cardiac Action Potential Phase 3 | Refractory Period Outward K flow until cells return to polarized resting state. In this phase the cardiac cell can be stimulated by a strong aberrent impulse. |
| P wave | depolarization of the atria |
| PR Interval | Delay as impulse travels from SA node to AV node |
| QRS Interval | Depolarization of ventricles |
| T wave | Repolarization of ventricles |
| QT Interval | Time from ventricular depolarization through repolarization |
| Non Drug Treatment for Arrhythmias | Ablation Implantable Cardiac Defibrillator (ICD) Elective Cardioversion Emergent Cardioversion |
| Class I Antiarrhythmic Drugs | Direct Membrane Action (Na channel blockade) Divided into Ia, Ib, Ic |
| Class II Antiarrhythmic Drugs | Beta Blockers |
| Class III Antiarrhythmic Drugs | Potassium Blockers (prolon repolarization) |
| Class IV Antiarrhythmic Drugs | Calcium channel blockers |
| Class Ia Effects | Conduction velocity- decreased Refractory period- prolonged Automaticity- decreased Ion blockade- Na EKG effects- Prolonted QRS and QT |
| Quinaglute, Quinidex, Cardioquin | Quinidine Class Ia Antiarrhythmic Ind: A flutter, A fib, SVT, VT, VF |
| Procan, Procan-SR, Procanbid, Pronestyl | Procainamide Class Ia Antiarrhythmic Ind: A flutter, A fib, VT, VF |
| Norpace, Norpace-CR | Disopyramide Class Ia Antiarrhythmic Ind: Ventricular arrhythmias |
| Class Ib Effects | Conduction velocity: neutral or decreased Refractory period: shortened Automaticity: decreased Ion blockade: Na (fast) EKG effects: shorten QT slightly |
| Xylocaine | Lidocaine Class Ib Antiarrhythmic Ind: Ventricular arrhythmia |
| Mexitil | Mexiletine Class Ib Antiarrhythmic Ind: Oral analog of lidocaine for ventricular arrhythmia prevention |
| Class II Effects | Conduction velocity: markedly decreased Refractory period: prolonged Automaticity: decreased Ion blockade: calcium (indirect) EKG effect: prolong PR |
| Tocainide | Class Ib Antiarrhythmic |
| Class Ic Effects | Conduction velocity: markedly decreased Refractory period: no effect Automaticity: decreased Ion blockade: Na (slow) EKG effect: prolonged PR and QRS/QT |
| Flecainide | Class Ic Antiarrhythmic |
| Moricizine | Class Ic Antiarrhythmic |
| Class III Effects | Conduction velocity: No effect Refractory period: markedly prolonged Automaticity: No effect Ion Blockade: Potassium EKG effect: prolonged QT |
| Coradone, Pacerone | Amiodarone Class III Antiarrhythmic ADRs include Blue, Gray skin tint Also blocks Ca, Na, and beta receptors |
| Bretylol | Bretylium Class III Antiarrhythmic Also blocks beta receptors |
| Betapace | Sotalol Class III Antiarrhythmic Also blocks beta receptors |
| Class IV Effects | Conduction velocity: Decreased Refractory period: prolonged Automaticity: decreased EKG effect: Prolonged PR |
| Calan, Calan SR, Covera-HS, Isoptin-SR | Verapamil Class IV Antiarrhythmic Ind: Acute use for supraventricular tachycardias (PSVT), HTN, and angina |
| Cardizem, Cardizem SR, Cardizem CD, Dilacor XR, Tiazac | Diltiazem Class IV Antiarrhythmic Ind: I.V. for A fib, A flutter, paroxysmal ventricular tachycardia |
| Lanoxin | Digoxin Class IV Antiarrhythmic Ind: Rate control in A. fib |
| Antidote for Digoxin | digibind |
| filler 1 | filler 1 |
| filler 2 | filler 2 |